Maxim Group Maintains Buy on Vivid Seats, Raises Price Target to $9
Maxim Group analyst Tom Forte maintains Vivid Seats (NASDAQ:SEAT) with a Buy and raises the price target from $7 to $9.
Maxim Group Maintains Buy on Ryde Group, Raises Price Target to $9
Maxim Group analyst Allen Klee maintains Ryde Group (AMEX:RYDE) with a Buy and raises the price target from $8 to $9.
Maxim Group Maintains Buy on PaySign, Raises Price Target to $6
Maxim Group analyst Michael Diana maintains PaySign (NASDAQ:PAYS) with a Buy and raises the price target from $5.5 to $6.
Maxim Group Maintains Buy on Beyond, Lowers Price Target to $36
Maxim Group analyst Tom Forte maintains Beyond (NYSE:BYON) with a Buy and lowers the price target from $50 to $36.
Maxim Group Initiates Coverage On NeuroBo Pharmaceuticals With Buy Rating, Announces Price Target of $10
Maxim Group analyst Jason McCarthy initiates coverage on NeuroBo Pharmaceuticals (NASDAQ:NRBO) with a Buy rating and announces Price Target of $10.
MY Morning Wrap | Sime Darby Plantation and PNB Propose 1,000-acre Green Industrial Park in Perak
Stocks to watch: Sime Darby Plantation, OCK.